ENOPOTANAB VEDOTIN

Enapotanab is an immunomodulatory compound investigated for inflammatory diseases. Side effects may include headache, fatigue, and mild GI upset. Only GMP materials will be supplied, logistics all according to GDP.

SKU: e7ab493c1f7c Category: Tag:

Product Description


Mechanism of Action

Enopotanab vedotin is an antibodydrug conjugate (ADC) consisting of a monoclonal antibody linked to the microtubuledisrupting agent monomethyl auristatin E (MMAE). Upon antigen binding and internalization, MMAE is released intracellularly, inhibiting tubulin polymerization and inducing apoptosis in target cells.

Benefits and Advantages

Used in ADCmechanism studies, targeted cancertherapy modelling, microtubuledynamics assays, and linkercleavage pharmacology research.

Side Effects and Risks

Risks include neutropenia, peripheral neuropathy, hepatotoxicity, infusion reactions and severe cytotoxicity. Handle with ADC and MMAEclass precautions.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

Protein

Molecular Weight

150000.0 g/mol

CAS Number

1615191-60-8

Storage Condition

Store in a cool, dry place; protect from light

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

IUPAC/Chemical Name

Antibodydrug conjugate

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download